Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 16/20 | 1.00 |
| ▸ | MMP9 | P14780 | 16/20 | 1.00 |
| ▸ | MMP8 | P22894 | 14/20 | 1.00 |
| ▸ | MMP1 | P03956 | 7/20 | 1.00 |
| ▸ | MMP3 | P08254 | 3/20 | 1.00 |
| ▸ | MMP14 | P50281 | 2/20 | 1.00 |
| ▸ | ADAM10 | O14672 | 1/20 | 1.00 |
| ▸ | ADAM12 | O43184 | 1/20 | 1.00 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 1.00 |
| ▸ | MMP7 | P09237 | 1/20 | 1.00 |
| ▸ | MMP12 | P39900 | 1/20 | 1.00 |
| ▸ | MMP13 | P45452 | 1/20 | 1.00 |
| ▸ | MMP15 | P51511 | 1/20 | 1.00 |
| ▸ | MMP16 | P51512 | 1/20 | 1.00 |
| ▸ | ADAM17 | P78536 | 1/20 | 1.00 |
| ▸ | ADAM9 | Q13443 | 1/20 | 1.00 |
| ▸ | MMP26 | Q9NRE1 | 1/20 | 1.00 |
| ▸ | MMP17 | Q9ULZ9 | 1/20 | 1.00 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ilomastat SCHEMBL6691646 | 1.00 | MMP2 (1.00) | MMP2MMP9MMP8MMP1MMP3 | |
| Ilomastat SCHEMBL4293696 | 1.00 | MMP2 (1.00) | MMP2MMP9MMP8MMP1MMP3 | |
| Ilomastat SCHEMBL4394885 | 1.00 | MMP2 (1.00) | MMP2MMP9MMP8MMP1MMP3 | |
| Ilomastat SCHEMBL7870487 | 1.00 | MMP2 (1.00) | MMP2MMP9MMP8MMP1MMP3 | |
| Ilomastat SCHEMBL13575799 | 1.00 | MMP2 (1.00) | MMP2MMP9MMP8MMP1MMP3 | |
| Ilomastat SCHEMBL8190117 | 1.00 | MMP2 (1.00) | MMP2MMP9MMP8MMP1MMP3 | |
| Ilomastat SCHEMBL35303 | 1.00 | MMP2 (1.00) | MMP2MMP9MMP8MMP1MMP3 | |
| SCHEMBL8394283 | 0.92 | MMP2 (0.85) | MMP2MMP9MMP8MMP1MMP3 | |
| SCHEMBL4845965 | 0.91 | MMP2 (0.84) | MMP2MMP9MMP8MMP1MMP3 | |
| SCHEMBL5558468 | 0.90 | MMP2 (0.82) | MMP2MMP9MMP8MMP1MMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4058037-B1 | FIBROBLAST-BASED THERAPY FOR TREATMENT AND PREVENTION OF STROKE | SPINALCYTE LLC (US) | 2026-01-28 | — | — | EP | claimed |
| US-20250332225-A1 | Injectable Neutral pH Collagen-Based Composition For Mesotherapy | SHANGHAI QISHENG BIOLOGICAL PREPARATION CO LTD (CN) | 2025-10-30 | — | — | US | claimed |
| EP-3866936-B1 | COSMETIC COMPOSITION WITH AN IMPROVED PICKUP | UNILEVER IP HOLDINGS B V (NL) | 2024-03-06 | — | — | EP | claimed |
| EP-3980477-B1 | A POLYMER AND A COSMETIC COMPOSITION COMPRISING THE POLYMER | UNILEVER IP HOLDINGS B V (NL) | 2023-01-04 | — | — | EP | claimed |
| US-20220370506-A1 | AUGMENTATION OF FIBROBLAST MEDIATED REGENERATION OF INTRAVERTEBRAL DISCS | FIGENE, LLC | 2022-11-24 | — | — | US | claimed |
| EP-4081261-A1 | AUGMENTATION OF FIBROBLAST MEDIATED REGENERATION OF INTRAVERTEBRAL DISCS | Figene, LLC (US) | 2022-11-02 | — | — | EP | claimed |
| US-20260133193-A1 | COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY DISEASES | UNIVERSITY OF WASHINGTON (US) | 2026-05-14 | — | — | US | disclosed |
| US-20260115231-A1 | TREATMENT OF CEREBRAL PALSY USING FIBROBLASTS | SPINALCYTE LLC (US) | 2026-04-30 | — | — | US | disclosed |
| EP-4058037-B1 | FIBROBLAST-BASED THERAPY FOR TREATMENT AND PREVENTION OF STROKE | SPINALCYTE LLC (US) | 2026-01-28 | — | — | EP | disclosed |
| US-12508287-B2 | Treatment of cerebral palsy using fibroblasts | SPINALCYTE LLC (US) | 2025-12-30 | — | — | US | disclosed |
| US-20250382240-A1 | 3-(5-SUBSTITUTED-4-OXOQUINAZOLIN-3(4H)-YL)-3-DEUTERO-PIPERIDINE-2,6-DIONE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME | SALARIUS PHARMACEUTICALS INC (US) | 2025-12-18 | — | — | US | disclosed |
| US-20250332225-A1 | Injectable Neutral pH Collagen-Based Composition For Mesotherapy | SHANGHAI QISHENG BIOLOGICAL PREPARATION CO LTD (CN) | 2025-10-30 | — | — | US | disclosed |
| US-20250288724-A1 | METHODS AND MATERIALS FOR USING FIBRIN SUPPORTS FOR RETINAL PIGMENT EPITHELIUM TRANSPLANTATION | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH | 2025-09-18 | — | — | US | disclosed |
| WO-2022096789-A1 | HICA FOR USE IN PROPHYLAXIS AND/OR TREATMENT OF A DISEASE OR CONDITION INVOLVING DEGRADATION OF CARTILAGE AND/OR DISRUPTION OF CARTILAGE HOMEOSTASIS AND/OR INTEGRITY | SALARUSTA OY (FI) | 2022-05-12 | — | — | WO | disclosed |
| CN-114375291-A | Novel compounds for skin lightening | 联合利华知识产权控股有限公司 | 2022-04-19 | — | — | CN | disclosed |
| CN-114341100-A | Novel compounds for skin lightening | 联合利华知识产权控股有限公司 | 2022-04-12 | — | — | CN | disclosed |
| US-20220098128-A1 | 3-(5-SUBSTITUTED-4-OXOQUINAZOLIN-3(4H)-YL)-3-DEUTEROPIPERIDINE-2,6-DIONE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME | SALARIUS PHARMACEUTICALS, INC. | 2022-03-31 | — | — | US | disclosed |
| US-11286251-B2 | Matrix metalloproteinase inhibitors and imaging agents, and methods using same | YALE UNIVERSITY (US) | 2022-03-29 | — | — | US | disclosed |
| CN-216055870-U | Distribution automation equipment electric automatization detection device | 范圣奇 | 2022-03-15 | — | — | CN | disclosed |
| WO-2022047486-A2 | DENTAL AND PERIODONTAL APPLICATION OF FIBROBLASTS | FIGENE, LLC (US) | 2022-03-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11286251-B2 | Matrix metalloproteinase inhibitors and imaging agents, and methods using same | MMP3, MMP1, MMP10 | MMP2 13/4885MMP9 8/4885MMP8 16/4885 |
| US-20260133193-A1 | COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY DISEASES | FCGR3B, FCGR2A, FCGR1A | MMP2 706/4885MMP9 489/4885MMP8 42/4885 |
| US-20250382240-A1 | 3-(5-SUBSTITUTED-4-OXOQUINAZOLIN-3(4H)-YL)-3-DEUTERO-PIPERIDINE-2,6-DIONE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME | IL5, TLR5, IDO1 | MMP2 3466/4885MMP9 2402/4885MMP8 971/4885 |
| US-20220098128-A1 | 3-(5-SUBSTITUTED-4-OXOQUINAZOLIN-3(4H)-YL)-3-DEUTEROPIPERIDINE-2,6-DIONE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME | IL5, IL15, CXCR5 | MMP2 3226/4885MMP9 2323/4885MMP8 851/4885 |
| US-12508287-B2 | Treatment of cerebral palsy using fibroblasts | PGF, CRH, HIF1A | MMP2 903/4885MMP9 2200/4885MMP8 207/4885 |
| US-20260115231-A1 | TREATMENT OF CEREBRAL PALSY USING FIBROBLASTS | PGF, FGF2, FGF1 | MMP2 769/4885MMP9 1002/4885MMP8 363/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.